网站首页
部门简介
招生工作
学科导师
培养工作
学位工作
就业工作
学生事务
研究生会
下载专区
研究生部 Department of Postgraduate Students 搜索
搜索
首页 > 学科导师 > 人类重大疾病生物治疗 > 博导
门可 人类重大疾病生物治疗
1986-05 | 博导

  • menke@scu.edu.cn

    • 肿瘤生物治疗基础与应用研究
  • 四川大学华西医院/生物治疗全国重点实验室门可研究员,博士生导师,四川省学术和技术带头人后备人选、四川省卫健委学术技术带头人后备人选。主要研究领域为恶性肿瘤的免疫基因治疗及新型核酸药物开发,重点围绕头颈部肿瘤、结直肠肿瘤等肿瘤类型开展创新基因治疗靶向发现和基因治疗技术开发。以一作/通讯身份在Signal Transduct. Target Ther.Adv. Funct. Mater.Adv. Sci.ACS NanoBiomaterialsJ Control Release等期刊发表论文30余篇。主持国家科技重大专项、国家自然科学基金、四川省重点研发项目等国家及省部级课题10余项,获授权国际和中国发明专利11项。主持研制的2项具有自主知识产权的肿瘤基因治疗候选药物品种已实现向企业技术转让,联合牵头开展多项创新肿瘤基因治疗技术的IIT临床研究

  • 四川省医学科技创新研究会头颈肿瘤临床研究分会副会长、中国医药生物技术协会基因编辑分会学术委员

  • 代表论著

    1. Wu J, Fu X, Chen X, Shuai M, Liu M, Li J, Gao Y, Zhang J, Zhu YZ, Zhou N, Duan X, Men K. Efficient cancer immunogenetherapy by tumor cell lysate modified mRNA formulation. Biomaterials. 2025;324:123466

    2. Lei S, Gao Y, Wang K, Wu S, Zhu M, Chen X, Zhou W, Chen X, Zhang J, Duan X, Men K. An Implantable Double-Layered Spherical Scaffold Depositing Gene and Cell Agents to Facilitate Collaborative Cancer Immunotherapy. ACS Nano. 2025;19(18):17653-17673

    3. Lei S, Li J, Zhu M, Zhou W, Fu X, Wu S, Chen X, Zhang J, Duan X, Wang W, Men K. Chimeric Antigen Receptor-Engineered Cell Membrane-Coated Nanoparticles Promote Dual-Targeted mRNA-Based Cancer Gene Therapy. ACS Nano. 2025;19(16):15668-15684.

    4. Men Ke, Liu M, Zhang X, Yang Y, Zhang R, Wang Y, Hu D, Zhou B, Yang L. Identification of Potent siRNA Delivery Peptides Using Computer Modeling. Adv Sci. 2024 4:e2308345.

    5. Gao Y, Wang K, Wu S, Wu J, Zhang J, Li J, Lei S, Duan X, Men Ke. Injectable and Photocurable Gene Scaffold Facilitates Efficient Repair of Spinal Cord Injury. ACS Appl Mater Interfaces. 2024 31;16(4):4375-4394.

    6. Yan Gao#, Kaiyu Wang#, Jin Zhang#, Xingmei Duan, Qiu Sun, Ke Men, Multifunctional nanoparticle for cancer therapy, MedComm, 2023, 11;4(1):e187

    7. Sibei Lei, Xiaohua Chen, Jieping Wu, Xingmei Duan, Ke Men, Small molecules in the treatment of COVID-19, Signal Transduct Target Ther, 2022, 5;7(1):387

    8. Sibei Lei, Yan Gao, Jingmei Li, Xiaohua Chen, Weilin Zhou, Jieping Wu, Pingchuan Ma, Ke Men*, Xingmei Duan*, Dual-RNA controlled delivery system inhibited tumor growth by apoptosis induction and TME activation, J Control Release, 2022, 344:97-112

    9. Weilin Zhou, Sibei Lei, Mei Liu, Dan Li, Yong Huang, Xiaoyi Hu, Jinrong Yang, Jing Li, Maorong Fu, Mengxi Zhang, Fengling Wang, Jiaqian Li, Ke Men*, Wei Wang*, Injectable and photocurable CAR-T cell formulation enhances the anti-tumor activity to melanoma in mice, Biomaterials, 2022, 291:121872

    10. Sibei Lei, Xiaohua Chen, Yan Gao, Ming Shuai, Weilin Zhou, Jingmei Li, Jieping Wu, Ke Men*, Xingmei Duan*, ALPPL2-Binding Peptide Facilitates Targeted mRNA Delivery for Efficient Hepatocellular Carcinoma Gene Therapy, Adv. Funct. Mater, 32 (2022) 2204342

上一篇:聂春来

下一篇:罗有福